Multi‐omics‐based analysis of high grade serous ovarian cancer subtypes reveals distinct molecular processes linked to patient prognosis

Despite advancements in treatment, high‐grade serous ovarian cancer (HGSOC) is still characterized by poor patient outcomes. To understand the molecular heterogeneity of this disease, which underlies the challenge in selecting optimal treatments for HGSOC patients, we have integrated genomic, transc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanshuo Alice, Neff, Ryan, Song, Won‐min, Zhou, Xianxiao, Vatansever, Sezen, Walsh, Martin J., Chen, Shu‐Hsia, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068328/
https://www.ncbi.nlm.nih.gov/pubmed/36637997
http://dx.doi.org/10.1002/2211-5463.13553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068328/
https://www.ncbi.nlm.nih.gov/pubmed/36637997
http://dx.doi.org/10.1002/2211-5463.13553

Ejemplares similares